Live·Verified funding discovery · 2026.2
886 grants · 20 open · 435 companies · 2640 concepts886 / 20 / 435 / 2640
⧗GRANTDocumentary Production · Screen Australia closes 24 SEPT⧗GRANTInstitutional Development Award (IDeA) for Clinical & Translational Research · National Institute of General Medical Sciences (NIGMS), National Institutes of Health closes 25 SEPT△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE886 grants in catalogue · 20 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA⧗GRANTDocumentary Production · Screen Australia closes 24 SEPT⧗GRANTInstitutional Development Award (IDeA) for Clinical & Translational Research · National Institute of General Medical Sciences (NIGMS), National Institutes of Health closes 25 SEPT△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE886 grants in catalogue · 20 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search

Rico Meinl

individual
Ecosystem influencer

About

Rico Meinl is a computational biology and applied AI leader at Retro Biosciences, where he works on protein engineering and cellular reprogramming for longevity biotech. Before Retro, he was the first employee at Talus Biosciences, building computational pipelines for drug discovery. He has also been recognized by Foresight Institute and has spoken publicly about AI for biology and aging research.

Areas of interest

longevitybiotechcomputational biologyapplied AIprotein engineeringcellular reprogrammingdrug discoverymachine learningbioinformatics